Genetic Risks for Bicuspid Aortic Valve Disease

计划入组 454 人 · 首次发布于 2013 年 4 月 4 日

Pathogenetic Basis of Aortopathy and Aortic Valve Disease

计划入组 3,000 人 · 首次发布于 2018 年 2 月 22 日

Identification of Genetic Causes of Calcific Aortic Valve Disease

计划入组 1,000 人 · 首次发布于 2019 年 11 月 4 日

liver disease program

siRNA therapeutics for ocular disease/dermatological disease (Phio Pharmaceuticals)

undisclosed drug (fibrotic liver disease/NASH), Engitix/Takeda

THUBRIKAR AORTIC VALVE INC

United States

HERSHEY VALVE CO., LTD.

Taiwan

Rare Disease Research, LLC

Low-Frequency Ventilation During Cardiac Surgery Protects Lung Function

EVOLVED Trial: Early Aortic Valve Replacement Fails to Show Mortality Benefit in Asymptomatic Patients with Fibrosis

CMS Reconsiders Medicare Coverage for TAVR in Asymptomatic Aortic Stenosis Patients Following Edwards' Request